Veronica R Rivera, MD
Obstetrics/Gynecology · San Jose
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 33
- 9 carriers
- Office
- 1
On the public record
- 1 Medical Board action on record
Offices
1 location
Looking this up.
Plans that list them
33 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Rivera’s office at (408) 905-7178 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
33 of 33 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A93252 · Current
Licensed to practise in California · since 2005 · expires 2027-10-31 · University of California San Francisco School of Medicine. Board flags: Public Reprimand.
Public record actions
| 2017-08-16 | Board disciplineDiscipline | Public reprimand. · 8002013000947 |
Original Medicare doctor bills
$22,744
Medicare paid this office $22,744 for 70 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 51 | $10,121 | $122 |
| New patient visit (45+ min) | 22 | $3,153 | $143 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 33 | $1,579 | $48 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 27 | $1,550 | $57 |
| Short return visit (20+ min) | 14 | $1,498 | $83 |
See all 7 services
| Return visit (30+ min) | 51 | $10,121 | $122 |
| New patient visit (45+ min) | 22 | $3,153 | $143 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 33 | $1,579 | $48 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 27 | $1,550 | $57 |
| Short return visit (20+ min) | 14 | $1,498 | $83 |
| Smear for infectious agents | 42 | $308 | $6 |
| Body fluid ph level | 42 | $193 | $4 |
Procedures Medicare counted
| Removal of skin lesions | 27 | More than 68% of doctors who do this |
Who their Medicare patients are
70 Original Medicare patients in 2024. Average age 74 · Women 100% · Also on Medicaid 17% · Health risk score 0.78. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
Conditions among them: High blood pressure 64% · Diabetes 27% · Coronary heart disease 19% · Chronic kidney disease 16% · Cancer 16%.
The office billed $46,700, Medicare allowed $28,326 and paid $22,744; for 351 services of 18 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 70 | 351 | 74 | 0.78 | $46,700 | $22,744 |
| 2023 | 62 | 341 | 74 | 0.91 | $41,640 | $19,023 |
| 2022 | 68 | 259 | 74 | 0.70 | $42,025 | $19,724 |
| 2021 | 64 | 266 | 73 | 0.79 | $45,210 | $21,737 |
| 2020 | 47 | 165 | 75 | 0.93 | $27,055 | $11,836 |
| 2019 | 71 | 244 | 74 | 0.94 | $36,100 | $16,838 |
| 2018 | 65 | 224 | 74 | 0.91 | $32,430 | $17,476 |
| 2017 | 65 | 177 | 75 | 0.93 | $27,980 | $13,385 |
| 2016 | 67 | 200 | 73 | 1.04 | $25,946 | $12,783 |
| 2015 | 70 | 255 | 73 | 0.77 | $41,723 | $19,870 |
| 2014 | 67 | 183 | 74 | 1.06 | $35,136 | $14,024 |
| 2013 | 75 | 200 | 73 | 0.82 | $29,300 | $15,251 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Return visit (30+ min) | 35 | $6,564 | $117 |
| Short return visit (20+ min) | 23 | $2,523 | $81 |
| New patient visit (45+ min) | 17 | $2,518 | $148 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 38 | $1,816 | $48 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 31 | $1,732 | $56 |
| Smear for infectious agents | 47 | $302 | $6 |
| Body fluid ph level | 53 | $228 | $4 |
2022: 6 services
| Return visit (30+ min) | 30 | $5,681 | $123 |
| New patient visit (45+ min) | 38 | $5,379 | $142 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 32 | $1,770 | $55 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 35 | $1,677 | $48 |
| Short return visit (20+ min) | 13 | $1,205 | $75 |
| Body fluid ph level | 20 | $77 | $4 |
2021: 6 services
| Return visit (30+ min) | 42 | $8,279 | $120 |
| New patient visit (45+ min) | 21 | $2,839 | $135 |
| Irrigation of vagina and/or application of drug to treat infection | 29 | $2,572 | $52 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 38 | $1,842 | $48 |
| Short return visit (20+ min) | 17 | $1,784 | $89 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 29 | $1,617 | $56 |
2020: 5 services
| Return visit (30+ min) | 18 | $2,865 | $95 |
| Short return visit (20+ min) | 29 | $2,573 | $64 |
| Irrigation of vagina and/or application of drug to treat infection | 11 | $1,002 | $37 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 13 | $626 | $48 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 11 | $600 | $55 |
2019: 5 services
| New patient visit (45+ min) | 27 | $3,659 | $136 |
| Return visit (30+ min) | 23 | $3,390 | $94 |
| Short return visit (20+ min) | 32 | $3,319 | $65 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 30 | $1,617 | $54 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 34 | $1,584 | $47 |
2018: 5 services
| Return visit (30+ min) | 32 | $5,225 | $107 |
| Short return visit (20+ min) | 34 | $3,024 | $74 |
| New patient visit (45+ min) | 14 | $2,286 | $163 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 35 | $1,701 | $49 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 26 | $1,533 | $59 |
2017: 5 services
| Short return visit (20+ min) | 33 | $3,117 | $68 |
| Return visit (30+ min) | 32 | $3,058 | $93 |
| New patient visit (45+ min) | 11 | $1,465 | $133 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 27 | $1,427 | $53 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 21 | $1,345 | $64 |
2016: 5 services
| Short return visit (20+ min) | 37 | $3,526 | $59 |
| Return visit (30+ min) | 23 | $2,402 | $86 |
| New patient visit (45+ min) | 13 | $1,581 | $122 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 35 | $1,554 | $44 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 25 | $1,356 | $54 |
2015: 6 services
| Return visit (30+ min) | 53 | $9,065 | $92 |
| New patient visit (45+ min) | 25 | $3,334 | $133 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 24 | $1,314 | $55 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 27 | $1,210 | $45 |
| Short return visit (20+ min) | 11 | $748 | $68 |
| Irrigation of vagina and/or application of drug to treat infection | 11 | $680 | $40 |
2014: 4 services
| Return visit (30+ min) | 50 | $7,270 | $90 |
| New patient visit (45+ min) | 13 | $1,743 | $134 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 27 | $1,213 | $45 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 15 | $819 | $55 |
2013: 5 services
| Return visit (30+ min) | 49 | $6,582 | $97 |
| New patient visit (45+ min) | 14 | $2,119 | $151 |
| Short return visit (20+ min) | 22 | $1,673 | $60 |
| Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 23 | $1,293 | $56 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 25 | $1,131 | $45 |
Medicaid work
$0 in 2024
Medicaid paid $0 for 47 billed services this clinician did in 2024, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 19 | $0 |
| Return visit (30+ min) | 28 | $0 |
| 2024 | 47 | 2 | 17 | $0 |
| 2023 | 31 | 2 | 18 | $0 |
| 2022 | 39 | 3 | 14 | $0 |
See the largest Medicaid services in earlier years
2023
| PH BODY FLUID NOT ELSEWHERE SPECIFIED | 12 | $0 |
| Short return visit (20+ min) | 19 | $0 |
2022
| PH BODY FLUID NOT ELSEWHERE SPECIFIED | 14 | $0 |
| New patient visit (45+ min) | 12 | $0 |
| Short return visit (20+ min) | 13 | $0 |
Drugs they prescribed that Part D paid
$25,166
Pharmacies billed $25,166 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 233) in 2024. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0%.
199 generic and 34 brand-name prescriptions · $25,166 in drug cost · 12 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Premarin | 12 | $5,626 | $469 |
| Estradiol | 93 | $4,587 | $49 |
| Trospium Chloride | 12 | $654 | $55 |
| Paroxetine | 11 | $56 | $5 |
| Fluconazole | 11 | $50 | $5 |
Year by year
| 2024 | 233 | 88 | 0% (0) | 15% | $25,166 |
| 2023 | 272 | 88 | 0% (0) | None | $39,579 |
| 2022 | 141 | 65 | 0% (0) | None | $17,864 |
| 2021 | 164 | 61 | 0% (0) | 23% | $23,998 |
| 2020 | 134 | 50 | 0% (0) | 22% | $19,610 |
| 2019 | 128 | 51 | 0% (0) | 41% | $19,989 |
| 2018 | 99 | 46 | 0% (0) | 22% | $12,236 |
| 2017 | 94 | 38 | 0% (0) | 33% | $14,837 |
| 2016 | 81 | 37 | 0% (0) | 46% | $17,161 |
| 2015 | 83 | 35 | None | 47% | $10,971 |
| 2014 | 95 | 39 | None | 46% | $9,751 |
| 2013 | 110 | 44 | None | 40% | $10,927 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Estradiol | 81 | $8,806 | $109 |
| Premarin | 14 | $6,902 | $493 |
| Fluconazole | 25 | $251 | $10 |
| Triamcinolone Acetonide | 25 | $120 | $5 |
| Hydrocortisone | 14 | $110 | $8 |
2022: 4 drugs
| Estradiol | 46 | $5,433 | $118 |
| Premarin | 14 | $4,893 | $349 |
| Fluconazole | 14 | $134 | $10 |
| Hydrocortisone | 11 | $90 | $8 |
2021: 4 drugs
| Premarin | 25 | $9,669 | $387 |
| Estradiol | 46 | $5,739 | $125 |
| Fluconazole | 13 | $116 | $9 |
| Hydrocortisone | 14 | $70 | $5 |
2020: 3 drugs
| Premarin | 14 | $5,441 | $389 |
| Estradiol | 35 | $5,198 | $149 |
| Fluconazole | 17 | $94 | $6 |
2019: 2 drugs
| Premarin | 29 | $9,711 | $335 |
| Estradiol | 33 | $4,032 | $122 |
2018: 3 drugs
| Premarin | 11 | $3,784 | $344 |
| Estradiol | 21 | $3,457 | $165 |
| Fluconazole | 14 | $112 | $8 |
2017: 2 drugs
| Premarin | 19 | $6,394 | $337 |
| Estrace | 20 | $5,642 | $282 |
2016: 2 drugs
| Premarin | 18 | $5,509 | $306 |
| Estrace | 16 | $4,192 | $262 |
2015: 2 drugs
| Premarin | 12 | $2,996 | $250 |
| Estrace | 13 | $2,885 | $222 |
2014: 2 drugs
| Premarin | 15 | $3,226 | $215 |
| Estrace | 18 | $2,925 | $162 |
2013: 1 drug
| Estrace | 27 | $3,823 | $142 |
Money from drug and device companies
$370 in 2025
| 2025 | 3 | 18 | None | $370 |
| 2024 | 5 | 27 | None | $307 |
| 2023 | 3 | 41 | None | $628 |
| 2022 | 2 | 16 | None | $145 |
| 2021 | 5 | 20 | None | $202 |
| 2020 | 2 | 3 | None | $46 |
| 2019 | 2 | 2 | None | $31 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Sumitomo Pharma America | Gemtesa | $199 | 6 payments
|
| Mayne Pharma Commercial | None | $153 | 11 payments
|
| Millicent US | Femlyv | $18 | 1 payment
|
See all 18 published payments
| Sumitomo Pharma America | Meals · 2025-12-05 | Gemtesa | $13 |
| Mayne Pharma Commercial | Meals · 2025-11-21 | None | $9 |
| Mayne Pharma Commercial | Meals · 2025-10-28 | None | $6 |
| Sumitomo Pharma America | Meals · 2025-09-25 | Gemtesa | $123 |
| Sumitomo Pharma America | Meals · 2025-09-09 | Myfembree | $15 |
| Millicent US | Meals · 2025-08-20 | Femlyv | $18 |
| Mayne Pharma Commercial | Meals · 2025-08-20 | None | $14 |
| Mayne Pharma Commercial | Meals · 2025-07-02 | None | $30 |
| Mayne Pharma Commercial | Meals · 2025-05-29 | None | $26 |
| Sumitomo Pharma America | Meals · 2025-05-16 | Myfembree | $23 |
| Mayne Pharma Commercial | Meals · 2025-05-02 | None | $10 |
| Mayne Pharma Commercial | Meals · 2025-04-16 | None | $9 |
| Sumitomo Pharma America | Meals · 2025-03-21 | Myfembree | $14 |
| Mayne Pharma Commercial | Meals · 2025-03-20 | None | $9 |
| Mayne Pharma Commercial | Meals · 2025-03-05 | None | $7 |
| Mayne Pharma Commercial | Meals · 2025-02-04 | None | $23 |
| Mayne Pharma Commercial | Meals · 2025-01-27 | None | $9 |
| Sumitomo Pharma America | Meals · 2025-01-03 | Myfembree | $12 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $307
| Mayne Pharma Commercial | None | $166 | 18 payments
|
| Exeltis USA | Tyblume | $84 | 5 payments
|
| Millicent US | None | $27 | 2 payments
|
| Sumitomo Pharma America | Myfembree | $17 | 1 payment
|
| Pfizer | Nurtec Odt | $14 | 1 payment
|
2023: $628
| Mayne Pharma Commercial | Nextstellis | $424 | 24 payments
|
| Exeltis USA | Tyblume | $184 | 16 payments
|
| Pfizer | Myfembree | $19 | 1 payment
|
2022: $145
| TherapeuticsMD | Annovera | $118 | 13 payments
|
| Organon | Nexplanon | $26 | 3 payments
|
2021: $202
| TherapeuticsMD | Annovera | $142 | 16 payments
|
| ASCEND Therapeutics US | Binosto | $18 | 1 payment
|
| Pfizer | Myfembree | $17 | 1 payment
|
| Organon | Nexplanon | $13 | 1 payment
|
| Mylan Pharmaceuticals | Xulane | $12 | 1 payment
|
2020: $46
| Merck Sharp & Dohme | Nexplanon | $25 | 2 payments
|
| AbbVie | Liletta | $21 | 1 payment
|
2019: $31
| Ortho Dermatologics a division of Bausch Health US | Duobrii | $19 | 1 payment
|
| Merck Sharp & Dohme | Nexplanon | $12 | 1 payment
|
Professional record
- NPI
- 1477734754
- Licence
- CA A93252California A93252: Current · expires 2027-10-31
- Trained
- University of California, San Francisco School of Medicine, 2004
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 706 N Winchester Blvd, San Jose, CA, 95128
- NPI first listed
- 2007-11-15
- NPI last updated
- 2015-07-31
This is when the NPI record was last certified, not a medical board exam.